Dermata Therapeutics, Inc.
DRMANasdaqCIK 1853816HealthcareFiscal year ends Dec 31
Reports and events: 132 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1708:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038647 |
| 2026-08-1116:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037127 |
| 2026-08-1116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037124 |
| 2026-08-0508:30 ET | 8-K | 8.01 Other events | 0001493152-26-036109 |
| 2026-06-0116:34 ET | SCHEDULE 13D | Ownership report, active investor | 0001493152-26-026642 |
| 2026-05-2716:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-025441 |
| 2026-05-1316:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022719 |
| 2026-05-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022710 |
| 2026-04-1717:01 ET | DEF 14A | Proxy statementPeriod 2026-04-17 | 0001493152-26-017909 |
| 2026-03-2617:17 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-012992 |
| 2026-03-2617:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012991 |
| 2026-02-2516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-008037 |
| 2026-02-2319:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-007792 |
| 2026-02-0316:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-004905 |
| 2026-02-0218:35 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-004801 |
| 2026-01-2709:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-003715 |
| 2026-01-0816:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-000967 |
| 2025-12-2916:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-029364 |
| 2025-11-1818:15 ET | 8-K | 1.02 Termination of a material agreement | 0001493152-25-023942 |
| 2025-11-1416:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023474 |
| 2025-11-1416:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-023419 |
| 2025-11-0716:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-021255 |
| 2025-09-1706:05 ET | 8-K | 8.01 Other events | 0001493152-25-013815 |
| 2025-09-1008:00 ET | 8-K | 8.01 Other events | 0001493152-25-012952 |
| 2025-08-2517:00 ET | 8-K | 8.01 Other events | 0001641172-25-025405 |
| 2025-08-1317:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023572 |
| 2025-08-1317:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023570 |
| 2025-07-3009:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-021501 |
| 2025-07-1617:45 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-019760 |
| 2025-07-0717:25 ET | 8-K | 3.01 Delisting notice | 0001641172-25-018042 |
| 2025-06-0516:31 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-013823 |
| 2025-06-0216:05 ET | DEF 14A | Proxy statementPeriod 2025-06-02 | 0001641172-25-013237 |
| 2025-05-2109:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001641172-25-011873 |
| 2025-05-1617:20 ET | 8-K | 3.01 Delisting notice | 0001641172-25-011286 |
| 2025-05-1409:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010112 |
| 2025-05-1409:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010111 |
| 2025-04-1508:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-004265 |
| 2025-04-0721:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-003085 |
| 2025-04-0318:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-002621 |
| 2025-03-2817:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001654954-25-003552 |
| 2025-03-2708:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-003372 |
| 2025-03-2517:29 ET | 8-K | 3.01 Delisting notice | 0001654954-25-003305 |
| 2025-03-1716:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-002886 |
| 2025-03-1716:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001654954-25-002885 |
| 2025-02-1318:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-006502 |
| 2025-01-2321:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-003484 |
| 2025-01-2316:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-000681 |
| 2025-01-2108:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-000570 |
| 2024-11-1418:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-014289 |
| 2024-11-1316:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001654954-24-014274 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:27 ET. Listed shows no prices and gives no investment advice.